Blog

  • Art exhibits that stand out over the Broad’s 10 years in Los Angeles

    Art exhibits that stand out over the Broad’s 10 years in Los Angeles

    Ten years ago, a new destination emerged in downtown L.A., bringing yet another architectural spectacle to Grand Avenue and bolstering the city’s art offerings. The Broad, home to the vast art collection of Eli and Edythe Broad, aimed to deliver world-class art to the masses for free.

    Originally set to debut in late 2014 (but delayed due to complications with the construction of the stark white facade known as “the veil”), the 120,000-square-foot museum opened Sept. 20, 2015. Public demand was so high it temporarily crashed the Broad’s online ticketing system.

    Since then, an estimated 6.7 million visitors have made their way inside to take in contemporary art by boldface names, among them Ed Ruscha, Robert Rauschenberg, Kara Walker and Mark Bradford. Special exhibitions by the likes of Jeffrey Gibson and Shirin Neshat, as well as an eclectic slate of concerts, film screenings and artist talks, have helped sustain the buzz among tourists and locals alike.

    But the first decade hasn’t been all sunshine and rainbow-colored Jeff Koons sculptures. Early on, critics panned the building’s unconventional design, calling it everything from “tight” and “unadventurous” to a “supersized cheese grater.” There’s been fuss about long lines and special exhibition pricing. When the pandemic hit, the museum was forced to shutter for 14 months and laid off 130 employees. Most recently, two former staffers sued the Broad for alleged discrimination, which the museum denies.

    Despite the critiques and setbacks, folks have continued to flock to Bunker Hill to take an otherworldly escalator ride and fill their social media feeds with images of Robert Therrien’s 10-foot table sculpture.

    To mark the Broad’s 10th anniversary, here are nine moments that stand out over the decade and one major development on the horizon.

    Lights, camera, Kusama

    Yayoi Kusama’s mirrored art continues to be a draw for Broad visitors.

    (Robert Gauthier / Los Angeles Times)

    Yayoi Kusama’s “Infinity Mirrored Room — the Souls of Millions of Light Years Away,” the installation that launched seemingly infinite Instagram posts, has kept millions of reservation-holding museumgoers lining up outside its first-floor chamber since the museum opened. Several hundred people per day wait for their chance to snap its constellation of LED lights that bounce off of wall-to-wall mirrors and the shallow layer of water surrounding the viewing platform.

    The special exhibitions begin

    A woman in a black jumpsuit stands against a white wall next to a painted portrait.

    Cindy Sherman poses at the Broad on June 7, 2016.

    (Christina House / Los Angeles Times)

    In June 2016, the museum debuted its first special exhibition, “Cindy Sherman: Imitation of Life,” which featured 120 self-portraits pulled from the Broad’s collection, the world’s largest holdings of Sherman’s photographic oeuvre. Spanning four decades, the exhibition displayed the artist’s transformation into myriad identities — from cinematic femme fatale to Rococo coquette — in full-color wall murals and framed black-and-white vignettes, as well as the 1997 feature film she directed, “Office Killer.”

    This marked the first time the museum charged an entry fee — $12 for adults to view this show.

    A grand makeover

    A man traverses a pedestrian crossing that's painted in bright blue, orange and green

    A man traverses a pedestrian crossing painted by Venezuelan artist Carlos Cruz-Diez on Sept. 14, 2017.

    (Frederic J. Brown / AFP / Getty Images)

    Timed to the citywide Pacific Standard Time: LA/LA event in 2017, the museum commissioned Carlos Cruz-Diez to create an outdoor installation — part of his “Couleur Additive” series — that livened up the corner of Grand Avenue and 2nd Street with swaths of green, orange and blue. The Venezuelan artist teamed up with high school students from Ramon C. Cortines School of Visual & Performing Arts to paint four crosswalks that brought much-needed color to the corridor.

    On view until it organically faded, the public artwork phenomenon tempted fearless pedestrians to throw caution to the wind as they raced out between traffic light cycles, and dodged aggressive drivers, in an attempt to capture the perfect selfie framed by the zigzagging optical art stripes.

    An American icon in focus

    A woman mounts an artwork showing three American flags painted on top of one another.

    Installers mount “Three Flags” by Jasper Johns on Jan. 31, 2018, at the Broad, ahead of the “Something Resembling Truth” exhibit’s February opening that year.

    (Allen J. Schaben / Los Angeles Times)

    Something Resembling Truth,” a survey of artist Jasper Johns put together in collaboration with the Royal Academy of Arts in London, brought his paintings, sculptures, prints and drawings together for a 2018 exhibition that was praised as “blissful.” Well-known works such as “Target” (1961) and his American flag and crosshatch paintings hung as a tribute to the living legend, whose works have been a part of the Broad’s collection since 1978.

    Say it loud …

    A painting shows three people, arms linked, behind an American flag with red paint dripping. One holds a knife.

    “The Flag Is Bleeding” by Faith Ringgold was part of the “Soul of a Nation: Art in the Age of Black Power 1963-1983” exhibition at the Broad, as photographed on March 18, 2019.

    (Francine Orr / Los Angeles Times)

    Soul of a Nation: Art in the Age of Black Power 1963-1983” celebrated more than 60 groundbreaking Black artists whose works embraced the beauty of African American culture while holding a mirror up to the civil rights injustices plaguing the country. This 2019 exhibition shined a light on the likes of Betye Saar, Noah Purifoy, Charles White and David Hammons, as well as art hubs across the country that once fostered Black creatives, including photographer Roy DeCarava and his seminal Kamoinge Workshop in New York City, Chicago’s AFRICOBRA collective and L.A.’s Brockman Gallery.

    The only West Coast appearance of the touring exhibition opened with a celeb-studded bash attended by Angela Bassett, Tina Knowles and Debbie Allen. The show included pieces on loan from the private collections of such tastemakers as Spike Lee, Beyoncé and Jay-Z. The Broad tapped Quincy Jones to curate an evening of live musical performances, as well as a soundtrack inspired by the exhibition.

    Farewell to an L.A. arts philanthropist

    Entrepreneur and philanthropist Eli Broad

    Entrepreneur and philanthropist Eli Broad is photographed in front of Cy Twombly’s “Untitled (Munich/Rome)” at his Los Angeles home on April 26, 2019.

    (Jay L. Clendenin / Los Angeles Times)

    On April 30, 2021, billionaire philanthropist Eli Broad died in Los Angeles. The real estate and insurance magnate started collecting art in the early 1970s alongside his wife, Edythe. The couple went on to amass more than 2,000 artworks, including pieces by Ellsworth Kelly, Roy Lichtenstein, Jean-Michel Basquiat and Andy Warhol. They established the Broad Art Foundation in 1984, which loaned artworks to institutions around the world.

    Broad, who retired from public life in 2017, left an indelible mark on the local art scene. He was a founding chairman of the Museum of Contemporary Art, invested in the creation of both an art center at UCLA and the Walt Disney Concert Hall, and was a benefactor to the Los Angeles County Museum of Art.

    Mr. DOB and his AR friends

    Takashi Murakami in his signature bright clothing with a surprised expression.

    Takashi Murakami photographed at the Broad on May 18, 2022.

    (Michelle Groskopf / For The Times)

    Japanese artist Takashi Murakami and his mouse-eared cartoonish alter ego, Mr. DOB, landed in 2022 with a parade of trippy mushroom sculptures covered in anime eyes and an 82-foot-long painting marrying traditional Taoism with modern-day manga. The immersive “Stepping on the Tail of a Rainbow” exhibit featured augmented reality experiences that let visitors use smartphones to bring new “life” to the vibrant, gory, goofy and grand pieces surrounding them. If you angled the Instagram app just so you’d glimpse a miniature metallic silver version of the artist greeting you, a comically muscly folklore demon towering behind you, or a pair of futuristic-looking avatars flanking paintings as though they were standing beside you IRL.

    A Pop art explosion

    Keith Haring art, including one focused on the AIDS hotline, hangs on a museum wall.

    Some of Keith Haring’s art on display at the Broad on May 23, 2023.

    (Dania Maxwell / Los Angeles Times)

    For the first time in L.A., a major exhibition of works by Keith Haring made its debut, filling 10 of the museum’s galleries with a lifetime’s worth of his signature bold black lines and electrifying hues. “Art Is for Everybody” transported guests from 2023 DTLA to 1980s downtown NYC. The collection of more than 120 items included subway drawings, throwback photos, vintage videos, activist posters drawing attention to causes of the time (including apartheid and AIDS awareness), as well as a re-creation of Haring’s Soho boutique, the Pop Shop. It was estimated to have attracted larger crowds than any other Broad exhibition — more than 170,000 visitors.

    Love letter to Black women

    Three Mickalene Thomas paintings of Black women on a white museum wall.

    A slice of “Mickalene Thomas: All About Love,” at the Broad.

    (Christopher Knight / Los Angeles Times)

    In May 2024, the Broad kicked off the first major international tour of “Mickalene Thomas: All About Love,” an exhibition devoted to Black women. Thomas represented her muses in poses that were dignified, glamorous, sensuous and exuberant, employing everything from acrylic paint to glitter and rhinestones to neon lights. Notably, the exhibition entrance replicated the artist’s childhood home in New Jersey and the first room swapped basic white gallery walls for two full-scale retro living room installations, all of which spoke to the importance of Black women having comforting safe spaces.

    Throughout the show, there were areas in which to lounge, reminisce, learn and rejoice. And a public programming lineup tied to the exhibition included self-care workshops, live music by Black femme musicians, plus a diverse showcase of queer stand-up comedians.

    An expansion in the works

    A rendering shows a white building with pop-out viewing areas from the street.

    Exterior rendering of the future Broad expansion from Hope Street.

    (Courtesy of the Broad. © Diller Scofidio + Renfro (DS+R))

    In April, the Broad held a groundbreaking ceremony for its forthcoming building expansion, which is expected to add 50,000 square feet to the museum, providing 70% more gallery space. With an entrance facing Hope Street, the smooth concrete addition will open out to the Grand Avenue Arts/Bunker Hill Metro station.

    Set to open in 2028 ahead of the Summer Olympic Games, the new design — drawn up by the building’s original architecture firm, Diller Scofidio + Renfro — comes with a $100 million price tag and will include new galleries, top-floor outdoor courtyards and live performance spaces. The renovations will also afford guests a chance to access “the vault,” the second-floor art storage space that has thus far only been visible through stairwell windows.

    Continue Reading

  • There’s a 90% chance we’ll see a black hole explode within a decade, physicists say

    There’s a 90% chance we’ll see a black hole explode within a decade, physicists say

    Stellar black holes form from the collapse of massive stars at the end of their lives, typically weighing 3 to 50 times the mass of the sun. When a star runs out of fuel, it explodes in a supernova, leaving behind a region so dense that nothing can escape, not even light.

    Primordial black holes, by contrast, are theoretical objects that could have formed less than a second after the Big Bang from extremely dense regions of the early universe. Unlike stellar black holes, they could be much lighter and are ancient relics from when the universe contained mostly hydrogen and helium.

    An image of the core region of Messier 87, home to a supermassive black hole, processed from a sparse array of radio telescopes known as the Event Horizon Telescope. (Image credit: Event Horizon Telescope)

    While black holes are typically known for consuming everything around them, physicists have long theorised that they eventually explode at the end of their lives through a process called Hawking radiation. Previously, scientists believed such explosions occurred only once every 100,000 years. However, new research, published in the journal Physical Review Letters, suggests we might witness this extraordinary phenomenon much sooner than expected.

    Continue Reading

  • In Netflix’s ‘Black Rabbit,’ Troy Kotsur wants to scare you

    In Netflix’s ‘Black Rabbit,’ Troy Kotsur wants to scare you

    “CODA,” the heartwarming drama about the child of Deaf adults, made a resounding noise at the 94th Academy Awards in 2022. In addition to winning for best picture, the film’s triumph was highlighted by Troy Kotsur, who made history as the first Deaf actor to win an Oscar.

    Kotsur’s performance as a father dealing with his struggling fishing business and the aspirations of his talented daughter — the only hearing member of the family — was anchored by humor and heartbreak, prompting many viewers to reach for tissues before the end credits.

    But fans of the Apple TV+ film are likely to do a double-take when they see Kotsur in Netflix’s new crime thriller “Black Rabbit.” The actor has switched from loving dad to breaking bad.

    In the limited series, Kotsur plays Joe Mancuso, a vicious criminal who has a deep connection to Jake and Vince Friedkin (played by Jude Law and Jason Bateman, respectively), the central characters of the drama. With a heavy beard and a lethal stare, he bears little resemblance to his Frank Rossi character in “CODA.”

    That difference is exactly what Kotsur wanted. Playing a bad guy fulfills one of his key ambitions. While he acknowledges that viewers might be initially thrown, he hopes they embrace his transition from tears to fears.

    Troy Kotsur as Joe Mancuso in Netflix’s “Black Rabbit.”

    (Netflix)

    “I really wanted to surprise the audience and play something that was exactly the opposite from Frank Rossi,” Kotsur said in a video call from his Mesa, Ariz., residence. His interpreter, Justin Maurer, participated in the discussion from Los Angeles.

    He added, “I want the audience to see that I’m able to do a different kind of role where I can be scary.”

    Kotsur also hopes that his portrayal in “Black Rabbit” continues to further the breakthroughs for Deaf artists that were generated by the success of “CODA.”

    “You see all these gangster movies where the bad guys have different nationalities,” Kotsur said. “They all speak the same language, but there wasn’t a villain who used sign language. Historically, there have been Deaf criminals, but our history has been marginalized.”

    As he signed, Kotsur was visibly excited about “Black Rabbit,” while also noting that the attention he had received after winning the supporting actor Oscar had taken him worlds away from his days as a struggling actor daydreaming as he drove past the gates of Warner Bros. and Paramount Studios.

    “There were a lot of dark times, really struggling financially,” he said. “I had to rely so much on my wife [actor Deanne Bray]. But when you win an Oscar, you’re more legitimate, more doors open. People listen and trust you and your ability.”

    He pointed to a painting on the wall behind him that captured a moment on his big Oscar night. “When they announced, I stood up, looked at my wife, said ‘Thank you’ and kissed her,” Kotsur said. “Someone took a picture of that, and it’s captured in this painting. It’s called ‘The Embrace.’ ”

    A profile shot of a man in a tan hat and dark suit standing.

    Troy Kotsur said he was looking for a role where he could play a bad guy: “Historically, there have been Deaf criminals, but our history has been marginalized.”

    (The Tyler Twins / For The Times)

    He’s also thrilled by the impact that “CODA” has had on Hollywood: “I’m seeing a slow transformation happening,” he said. “It’s really amazing to see the change, to have more meetings and more conversations before we shoot. Everyone wants to have that cultural sensitivity with deaf culture and sign language. I’m really glad to see it while I’m still alive.”

    His bad-guy hunger was fueled by a memorable pre-”CODA” incident.

    “I had a beard and pretty long hair at the time,” Kotsur recalled.”I was in an elevator, and I was tired. I pushed a button, but nothing seemed to be happening. Then the door opened, and there were two women, who were so surprised and frightened when they saw me that they started screaming. They wouldn’t even get into the elevator!

    “I felt hurt — ‘Why are these women so afraid of me?’ I didn’t realize how I looked at the time. But I kept that moment in my tool bag and thought, ‘One day I hope I can play a character that people can be scared of. So with ‘Black Rabbit,’ here’s my opportunity.”

    Mancuso is just one of the many dark elements populating the series, the latest project from Riff Raff Entertainment headed by Law and partner Ben Jackson.

    In “Black Rabbit,” Law’s Jake Friedkin co-owns a swanky new restaurant and VIP lounge that is fast becoming a New York hot spot. But the sudden arrival of Vince, who has a history of addiction, gambling and bad behavior, puts the siblings on a relentless spiral of mayhem and violence.

    Mancuso is first glimpsed in the second episode in his lair deep in the basement of a Russian bath house. Signing with one hand, he glowers as he makes it clear to his bookies — son Junior (Forrest Weber) and Babbitt (Chris Coy) — that he is unhappy they have not yet collected on Vince’s massive gambling debt.

    Two men standing in front of a desk, facing an unseen man.

    Babbitt (Chris Coy) and Junior (Forrest Weber) work for Mancuso as bookies.

    (Netflix)

    Later in the episode, he displays warmth flavored by familiarity with Jake as the two negotiate a payment plan to pay off the debt. But when the encounter gets more tense, Mancuso unveils his lethal side, his smile dissolving into a sinister glare as he knocks a cup of hot coffee into Jake’s lap.

    “I get to have a sweet little arc where I go from friendly to mean,” he said, flashing a smile. “And wow, I actually get to spill coffee on an A-lister! It was cool and fun.”

    Bateman, an executive producer who directed the first two episodes, provided Kotsur with guidance on how to play the scene.

    “Jason said, ‘I want you to do something simple,’ ” said Kotsur. “He said, ‘You have this one line — “How much money?” — and you should have just a little smile. Then you go back to counting your money and working on your books.’ That gave me a clue. Less is more, which as an actor I’m a big believer in.”

    He added, “Hearing villains can talk and point at the same time. But a deaf villain would have to think how to approach that. I hope the audience recognizes some of the subtleties. I wanted to keep Mancuso under control, keep the seething under the surface and show the power.”

    And while Rossi was animated while signing, Mancuso is pointedly more subdued. “He only uses one hand when he signs. If you think about it, maybe he has a gun in the other hand, or maybe the gun is in his waistband,” he said. “Because Mancuso is in control, my portrayal needed to be in control. Other people might be in a rush, but Mancuso is not. He knows he will be the last person in the room, the last person to challenge.”

    The role was specifically written for Kotsur by Zach Baylin and Kate Susman, who created the project. The couple met Kotsur on the 2022 awards circuit where “CODA” was a constant presence.

    A man in a tan hat and dark striped suit sits with his arms crossed and one hand hear his chin.

    “We believed he had a tremendous range that could play almost anything,” said Zach Baylin, who created “Black Rabbit” with Kate Susman. The pair wrote the role of Joe Mancuso for Kotsur.

    (The Tyler Twins / For The Times)

    “Troy is such a compelling, larger-than-life figure,” said Baylin, who received an Oscar nomination for his screenplay of 2021’s “King Richard” starring Will Smith. “He’s funny and gregarious, and we just had a great time socially with him. We believed he had a tremendous range that could play almost anything.”

    When Baylin and Susman asked Kotsur what he wanted to do next, he told them he really wanted to play a bad guy.

    “That really stuck with me and Kate, and we had that in our back pocket for three or four years,” Baylin said. “We wrote that role for him without telling him, excited about an actor with his presence and power who could play something menacing but also show the humanity and emotion he displayed in ‘CODA.’ He brings a powerful stillness to his performance that wasn’t necessarily on the page.”

    Susman said Kotsur displays a lot of depth: “You can see it, like there’s a storm brewing behind his eyes. We were so happy, and frankly relieved when he said he would do the show.”

    Weber, who shares several scenes with Kotsur where they converse in sign language, said he was awed when he met the Oscar winner on the first day of rehearsals.

    “It was like hitting the jackpot for the second time after I got the role,” said Weber, who said he learned sign language as a child, before he could even talk, because his older sister is Deaf.

    He continued: “There’s such a gravity with Troy. In between takes, he’s the most fun, outgoing guy in the world. But when he was in character, he was absolutely terrifying.”

    Kotsur said he worked on developing a backstory for his character that helped him in his scenes with Law and Bateman, but also in an episode later in the season when he plays a younger version of Mancuso.

    “It’s important for me as an actor to look at the backstory and journey of the character — why would Mancuso be working in the basement of a bathhouse?” he said. “What would bring him to that point. I thought, ‘What if he was a janitor when he was younger, and someone noticed and trained him?’ All the other mobsters felt safe because Deaf people can’t hear conversations. So he develops this trust, and gets more and more responsibility. And he winds up running the business.”

    Now that Kotsur, who appears in the recently completed third season of Apple TV+‘s “Foundation” and will star in the upcoming horror film “Primate,” can cross off “playing a bad guy,” he has other ambitions: “I would love to do a Western. Also a comedy.”

    Continue Reading

  • Ackroyd & Harvey: The Art of Activism review – culture and politics collide in film of eco-artist double act | Film

    Ackroyd & Harvey: The Art of Activism review – culture and politics collide in film of eco-artist double act | Film

    On the question of whether art and politics can be productive bedfellows, artists Heather Ackroyd and Dan Harvey (the subjects of this baggy but wise documentary) show it’s all about the grassroots. Literally; among the works highlighted here are the grass coats that put Extinction Rebellion (XR) on the front pages during London fashion week in 2019, and the giant photosynthesised portraits in turf they have been making for 30 years.

    Such indelible images are worth their weight in marketing gold to today’s green crusaders. But the ecological cause has long been integral to Ackroyd and Harvey’s art, down to its conception and fabrication; a fusion of art and science that harks back to the Enlightenment, when the intelligentsia dabbled in a bit of everything. Impaling diseased ash trunks with porcupine-like spines, or dissecting a beached minke whale carcass to crystallise its skeleton, their work has a naturalist’s field knowledge and rigour.

    But even backed by this kind of fastidious practice, can culture realistically be expected to have tangible political impact? Once the furore from their involvement in the Culture Declares Emergency movement died down, as director Fiona Cunningham-Reid follows the artists into the XR circus, it seems that the answer gets lost, as it so often does with activism. Life takes over, as demonstrated by the film’s second half chronicling the Covid period and beyond. Though Ackroyd and Harvey continue to make commissions, their marriage and what one commentator calls their “personal symbiosis”, disintegrate.

    While the film is a bit euphemistic about the nature of their rift, one squabble is illuminating: Ackroyd at one point laments the “degradation” of their installations, while Harvey views it as “transition”. They finally choose to go separate ways professionally, with Ackroyd wanting to return to her performance-art roots.

    But perhaps this acceptance of slow, imperceptible change holds the key to their political significance. Positively shaping the long-term landscape, as the hippy revolution did before them, is just as important as dramatic breakthroughs. Like the acorns from Joseph Beuys’s 7,000 Oaks sculpture – which, thanks to Ackroyd and Harvey’s stewardship, end up as trees on the Tate Modern terrace – you never know what the seeds of culture will produce.

    Ackroyd & Harvey: The Art of Activism is in UK cinemas from 19 September

    Continue Reading

  • Malnutrition causes unrecognised type of diabetes: experts – France 24

    1. Malnutrition causes unrecognised type of diabetes: experts  France 24
    2. Mysterious diabetes variant with 25 million cases gets a name  The Hindu BusinessLine
    3. Experts seek formal classification of ‘type 5’ diabetes, advanced research  Hindustan Times
    4. Millions Could Be Overlooking New Type 5 Diabetes, Warn Experts; Know the Signs  Times Now
    5. Type 5 diabetes: Why the malnutrition-related condition needs to be formally recognised?  IANS LIVE

    Continue Reading

  • As US funding falters, mRNA cancer vaccine pioneers face new hurdles

    As US funding falters, mRNA cancer vaccine pioneers face new hurdles

    Cuts to mRNA vaccine funding in the US have stalled infectious disease programmes, with experts warning the consequences are likely to extend to other promising therapeutic areas.  

    It was only a matter of time before mRNA technology moved into the regulatory crosshairs of Robert F Kennedy Junior (RFK Jr). The health secretary has continually voiced his criticism of mRNA-based Covid-19 vaccines, questioning both their efficacy and safety.

    Discover B2B Marketing That Performs

    Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

    Find out more

    In August, Dr Amesh Adalja of the Johns Hopkins University Center for Health Security in Baltimore told Pharmaceutical Technology that mRNA vaccines are being unfairly stigmatised by government agencies.

    At the time, Dr Adalja anticipated that “it will only get worse.”

    Indeed, it has. Changes to vaccine guidelines and recommendations overseen by RFK Jr have drawn criticism from senior leaders at the Centers for Disease Control and Prevention (CDC), but the severing of federal funding to mRNA projects was an abrupt wake-up call to the life sciences sector.

    Risks to promising mRNA cancer vaccines

    In August, RFK Jr cut $500m worth of mRNA vaccine research funding, impacting around 22 projects being run at the Biomedical Advanced Research and Development Authority (BARDA). Grants withdrawn were those for infectious disease vaccine candidates, with RFK Jr claiming the modality is ineffective against upper respiratory tract infections.

    Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken against mRNA vaccines. Prasad said it was a “wise decision” to deprioritise mRNA vaccine technology research, citing unknown long-term safety and better alternatives.

    It was a major setback for mRNA research & development (R&D), which has steadily grown in activity over the past eight years. When removing the anomaly of a significant uptick in 2021 amid Covid-19 vaccine research, the number of global mRNA vaccine trials initiated in 2024 was more than five times those started in 2017.

    The US funding decision also impacted other mRNA-based technology initiatives run by the agency, such those showing promise in oncology.  Although still in relatively early-stage clinical trials, several vaccine candidates have shown efficacy in fighting pancreatic, prostate, and skin cancer, amongst others. Analysis by GlobalData indicates there are 232 clinical trials evaluating mRNA vaccines in oncology indications, a value far higher than any other therapeutic area excluding infectious diseases.

    Prasad’s criticisms of mRNA vaccines do not stop at infectious diseases – he claims there is a “sea of negative findings” of the modality’s application in cancer. This contradicts the findings of recent early-stage trials evaluating several mRNA vaccines in various cancers. 

    Regardless, Prasad’s views are especially pertinent, given that he heads up the department ultimately responsible for approving any future mRNA vaccine in a cancer indication.

    Given the shared nature of the technology in infectious diseases and oncology, experts are concerned that the policy shifts could spread to this ongoing research with mRNA vaccines in cancer patients.  

    “It will probably have an effect. What’s more concerning for me is just the fact that there is there seems to be a general attack on science in America. mRNA vaccines are a really promising technology, and it seems to have been shut down,” says Dr Shivan Sivakumar, associate professor at the University of Birmingham, which developing mRNA cancer vaccines.

    Dr Sivakumar is principal investigator of an international, multicentre, randomised Phase II trial evaluating BioNTech’s mRNA vaccine BNT-122 as a preventative treatment option for pancreatic cancer.

    “I think [the policy shifts in the US] are quite concerning because it’ll have an impact on the development of novel vaccination strategies against both infectious diseases and cancer,” Dr Sivakumar adds.

    A US medical oncologist studying mRNA cancer vaccines agrees.

    “There’s going to be some effects, obviously, because there’s this general title of mRNA vaccine research that’s tagged to it,” says Dr Jeff Yorio, lead trial investigator at Texas Oncology–Austin Central and one of the local sites leads for a global phase III trial testing Merck and Moderna’s mRNA vaccine candidate to prevent melanoma recurrence.

    “Hopefully we continue focus on it and put resources behind it.”

    Health secretary battles back

    RFK Jr has defended his stance on mRNA vaccines. In a fiery Senate hearing on 4 September, he said he ‘agreed’ with a statement made by Dr Robert Malone that suggested mRNA vaccines cause serious harm and even death in young people.

    Dr Malone is an anti-vaccine activist who has spread misinformation about coronavirus and associated vaccines. More recently, he blamed, without evidence, hospital error as the cause of recent paediatric deaths in children with measles, rather than the lack of immunisation against the disease. Dr Malone claims to have played an integral role in the creation of the mRNA vaccine, though Covid-19 experts have debunked this.

    Meanwhile, there is no evidence to suggest mRNA vaccines cause ‘serious harm’ to young people. A 2025 study analysed 1 million individuals who received an updated mRNA Covid-19 vaccine containing the JN.1 lineage – a version that protects against most strains of the virus. The researchers found no statistically significant increase of recipients needing to go to hospital.

    Dr Yorio says that safety aspects will need to be continually reviewed as the vaccine’s development in cancer accelerates, but maintains the modality is an area of high promise on the oncological spectrum.

    “mRNA vaccines shifted into rapid production during Covid-19. But for oncology, it’s a much more complicated version of an infectious disease. Virus infections are mostly uniform. But the big problem with cancers is that everybody’s cancer is a little unique,” Dr Yorio explains.

    Pharma unites amid political tension

    With political attitude in the US shifting away from mRNA technology, other immunotherapeutic approaches are on standby to fill the potential void.

    “It’s possible that that if other research focused on mRNA technology can’t advance in certain cancers, then other modalities may step into the gap,” says Paul Peter Tak, CEO of Candel Therapeutics, a biotech developing viral immunotherapies for several cancers.

    Candel Therapeutics is not involved in developing mRNA vaccines, so Tak is confident the funding cuts and policy shifts won’t affect his company’s platform. However, he says treating patients is the end goal, and expresses concern that promising mRNA research is being stalled.  

    “When I think about other companies that develop mRNA-based vaccines for cancer, I don’t see them as competitors but as colleagues meeting this incredible unmet need. I like companies to be set up for success,” adds Tak.

    “There’s no doubt that mRNA technology has been a breakthrough in the world of vaccinations. I regret these decisions that have become politicalised.”

    Tak’s remarks reflect a shared sentiment amongst many in the pharmaceutical industry who are concerned about the political attack on mRNA technology. Scientists on the frontline of research and executives of companies funding clinical candidates are unanimous in the promise mRNA vaccines have as an immunotherapy treatment avenue for cancers. Indeed, RFK Jr’s vaccine views have even drawn bipartisan criticism on Capitol Hill, with Republican and Democratic senators joining forces to uphold scientific integrity.

    “In your confirmation hearings you promised to uphold the highest standards for vaccine. Since then, I’ve grown deeply concerned,” Republican Senator John Barrasso told RFK Jr during the senate finance committee hearing on 4 September.

    “If we’re going to make America healthy again, we can’t allow public health to be undermined.”



    Continue Reading

  • Ajax 0-2 Inter Milan: France Star Striker A ‘Specialist’ But Italy Megastar Continues To Falter

    Ajax 0-2 Inter Milan: France Star Striker A ‘Specialist’ But Italy Megastar Continues To Falter

    Marcus Thuram went from strength to strength in Inter Milan’s 2-0 win at Ajax, but Nicolo Barella failed to impress.

    According to Corriere dello Sport via FCInterNews, the Italian midfielder’s performance left a lot to be desired.

    Advertisement

    Only days after Inter’s frustrating defeat at Juventus, Cristian Chivu’s side returned to the win column with a bang.

    Indeed, Marcus Thuram slotted home two identical headers in both halves to get Inter’s Champions League season off to a flyer.

    Marcus Thuram Impresses in Ajax 0-2 Inter Milan Win, Nicolo Barella Flops

    CHARLOTTE, NORTH CAROLINA – JUNE 30: Nicolo Barella #23 of FC Internazionale Milano looks on prior to the FIFA Club World Cup 2025 round of 16 match between FC Internazionale Milano and Fluminense FC at Bank of America Stadium on June 30, 2025 in Charlotte, North Carolina. (Photo by Michael Reaves/Getty Images)

    Advertisement

    Nicolo Barella was merely a shadow of his former self against Juventus last weekend.

    However, Chivu decided against dropping him out of his starting line-up.

    Unfortunately, the diminutive midfielder offered no improvement on his performance in Turin.

    Indeed, the ex-Cagliari star lacked energy and composure in critical moments.

    Despite improving slightly after the break, it was not one of his best showings in the Nerazzurri shirt.

    On the other hand, Stefan de Vrij was superb in his first competitive start under Chivu.

    Indeed, he forged a wall in front of Yann Sommer’s goal alongside Alessandro Bastoni and Manuel Akanji.

    Continue Reading

  • The 5-methylcytosine DNA glycosylase ROS1 prevents paternal genome hypermethylation in Arabidopsis endosperm | Genome Biology

    The 5-methylcytosine DNA glycosylase ROS1 prevents paternal genome hypermethylation in Arabidopsis endosperm | Genome Biology

    ROS1 contributes to endosperm DNA methylation patterning

    Gene expression data indicate that all four 5-methylcytosine DNA glycosylases are expressed in endosperm [36] (Additional file 1: Fig. S1A). To determine whether 5-methylcytosine DNA glycosylases other than DME contribute to the endosperm DNA methylation landscape, we profiled DNA methylation in the absence of ROS1 and in the absence of ROS1, DML2, and DML3. We performed enzymatic-methyl sequencing (EM-seq) on three replicates each of wild-type Col-0, ros1, and ros1-3 dml2-1 dml3-1 (rdd) endosperm. For ros1 profiling, we used both ros1-3 mutants, which have a T-DNA insertion in exon 7, and ros1-7 mutants, which have a missense mutation such that a conserved glutamic acid residue in the DNA glycosylase catalytic domain is changed to a lysine residue [8, 37] (Additional file 1: Fig. S1B). We used two different mutant alleles of ros1 so we could confirm that observations were not line-specific. Based on previous studies, ros1−7 is expected to be a hypomorphic allele [37], whereas ros1−3 is a null allele [8]. For all samples, endosperm nuclei were isolated from whole seeds at 7 days after pollination (DAP) by fluorescence-activated nuclei sorting (FANS) based on their triploid DNA content (Additional file 1: Fig. S1C). We obtained methylomes of 98 to 194x genome coverage with high conversion rates (Additional file 2: Table S1). To facilitate direct comparison between endosperm and a vegetative tissue, we also profiled methylation in three replicates each of wild-type Col-0, ros1-3, and ros1-7 rosette leaves, isolating 2 C and 4 C nuclei by FANS (Additional file 1: Fig. S1D, Additional file 2: Table S1). Globally, the total fraction of endosperm methylated cytosines was greater in rdd than wild-type in the CG and CHG sequence contexts (Fig. 1A, p < 0.05, unpaired t-test, Bonferroni-corrected) but was not significantly different between ros1-3 and wild-type or ros1-7 and wild-type (Fig. 1A, p > 0.05, unpaired t-test, Bonferroni-corrected). To identify potential discrete regions of differential methylation we used Dispersion Shrinkage for Sequencing Data (DSS) to identify differentially methylated regions (DMRs) between the demethylase mutant endosperm and the wild type in the CG, CHG, or CHH methylation sequence contexts [38, 39] (Fig. 1B, C). The ros1-3 mutation is linked to genomic regions from the Ws ecotype on chromosome 2; these regions were removed from analysis in ros1-3, ros1-7, and Col-0 prior to identifying DMRs to avoid calling false-positive DMRs due to ecotype-specific methylation differences [8, 20]. For identifying DMRs between rdd and Col-0, we removed from consideration regions of the Ws genome on chromosomes 2 and 3 that are linked to ros1-3 and dml2-1, respectively [8, 20]. Using DSS, we identified 1,624 total DMRs in any sequence context between ros1-3 and Col-0, 913 total DMRs between ros1-7 and Col-0, and 1,319 total DMRs between rdd and Col-0 (Additional file 3: Table S2). We partially attribute the lower number of DMRs called in rdd relative to ros1-3 to greater variability between rdd biological replicates. Consistent with the molecular function of DNA demethylases, most DMRs were more highly methylated in demethylase mutant endosperm compared to wild-type endosperm; these are referred to as “hyperDMRs” (Fig. 1C, Table 1). The DMRs were short, with the most abundant fraction being 50–100 bp in length (Additional file 1: Fig. S2A). By genome browsing, we observed that DMRs identified by DSS were often surrounded by regions that also appeared differentially-methylated but were not called as DMRs (Fig. 1B). To further investigate, we calculated methylation levels in 50 bp windows 1 kb 5′ and 3′ of hyperDMRs (Additional file 1: Fig. S3). Regions flanking hyperDMRs were more methylated in ros1 mutant backgrounds than they were in wild-type, up to a few hundred base pairs from the center of the DMR (Additional file 1: Fig. S3).

    Fig. 1

    ROS1 prevents endosperm hypermethylation. A Fraction of cytosines by sequence context that are methylated in wild-type Col-0, ros1-7, ros1-3, and rdd in 3 C and 6 C endosperm nuclei. Error bars represent standard deviation from the mean. B Example of a region (Chr5, 9,271,400–9,272,200) with DNA hypermethylation in all demethylase mutant backgrounds in the endosperm (blue=mCG, gold=mCHG, green=mCHH). C Total length of hyperDMRs (left) and hypoDMRs (right) by sequence context in each mutant. D Methylation of ros1-3 (blue) or ros1-7 (orange) hyperDMRs in Col-0, ros1-7 or ros1-3 endosperm, representing weighted average fraction mC for each ros1 hyperDMR by sequence context. One biological replicate of each genotype is shown, additional replicates presented in Additional file 1: Fig. S4. Plot is a Tukey’s box plot. E The number of ros1-3 and ros1-7 hyperDMRs (after merging hyperDMRs identified across sequence contexts into a single list of target regions) found within 1 kb of or intersecting a feature. 1000 randomly selected control regions with low DNA methylation in WT endosperm (<50% in all sequence contexts) were also analyzed

    Table 1 Regions of interest identified in this study

    The fewer ros1-7 hyperDMRs identified compared to ros1-3 are consistent with the expectation of ros1-7 as a hypomorphic allele and ros1-3 as a null allele (Fig. 1C, Additional file 1: Fig. S1B). To assess the replicability of hypermethylation across the mutant genotypes, we calculated the weighted average of DNA methylation at ros13 and ros17 hyperDMRs in all genotypes (Fig. 1D, Additional file 1: Fig. S4). Across replicates and genotypes, ros1 mutants were more highly methylated than Col-0 at hyperDMRs identified in either ros1 mutant background, indicating a high degree of similarity between the two ros1 mutant genotypes. Finally, our analysis of methylation across genotypes showed that disruption of DML2 and DML3 caused only minor increases in endosperm methylation compared to loss of ROS1 alone (Fig. 1C, Additional file 1: Fig. S4). Thus, we focused our additional analyses and experiments on ROS1.

    ROS1 prevents DNA methylation spreading from a subset of TEs in the endosperm

    ROS1 is known to maintain DNA methylation boundaries at TEs, preventing aberrant DNA methylation “spread” [9, 10, 40]. The hypomethylation of the wild-type endosperm genome relative to leaf and seedling tissues prompted us to further investigate the impact of ROS1 at TE boundaries in endosperm. To identify features of endosperm ROS1 targets, we first merged ros1 hyperDMRs (Table 1) from all cytosine sequence contexts. Consistent with previous results, these regions were often found near TEs; over half were within 1 kb of or intersecting a TE (representing 1463 of the 34856 Araport11-annotated TE fragments for ros1-3, and 624 for ros1-7) (Fig. 1E). For subsequent analyses, we refer to the 1463 TEs within 1 kb of or intersecting a ros1-3 hyperDMR as ROS1 TEs (Additional file 4: Table S3). Seventy-nine percent of the DMRs associated with ROS1 TEs were in the 1 kb flanking regions, rather than in the TE body. In wild-type endosperm, ROS1 TEs were less methylated in flanking regions (~26% CG methylation) than non-ROS1 TEs (~40% CG methylation), with a sharper boundary between methylation in the flanking region and in the body of the TE (Fig. 2A, Additional file 1: Fig. S5, 6). Additionally, in ros1 mutant endosperm, we observed DNA methylation spreading up to ~1 kb beyond the ends of ROS1 TEs (Fig. 2A). Similar results were obtained for ROS1 TEs defined using the ros1-7 methylation data (Additional file 1: Figs. S5, S6). To investigate any endosperm-specific features of ROS1 TEs, we compared DNA methylation levels of the same TEs in leaves (Additional file 1: Figs. S5, S6). The total level of CG DNA methylation at both ROS1 TEs and non-ROS1 TEs was lower in the endosperm than in leaves (Additional file 1: Figs. S5, S6), consistent with endosperm DNA hypomethylation. However, the magnitude of increased CG methylation flanking ROS1 TEs was not different between endosperm and leaf. We note that bodies of both ROS1 and non-ROS1 TEs have higher levels of non-CG methylation in endosperm relative to leaf (Additional file 1: Figs. S5, S6). Overall, we conclude that ROS1 enforces sharp methylation boundaries at a subset of TEs in the endosperm, as it does in leaves.

    Fig. 2
    figure 2

    ROS1 prevents DNA methylation spreading from TEs in the endosperm. A Average percent CG methylation determined in 100 bp windows 2 kb outside and 2 kb inside of ROS1 TEs (left, n = 1463). ROS1 TEs gain DNA methylation at their boundaries in ros1 mutant endosperm, and are hypomethylated at their boundaries in wild-type endosperm relative to non-ROS1 TEs (right, n = 33279). B The difference between median ros1-3 mCG and median Col-0 mCG value at each 100 bp window 2 kb outside and 2 kb inside of methylated ROS1 TEs (>10% mC in all sequence contexts in all Col-0 replicates). C Underlying data for Fig. 2B, the median ros1-3 mCG value (left) and the median Col-0 mCG value (right). Gray represents no data. Order of TEs is the same in B and C.

    Whereas the function of ROS1 in maintaining DNA methylation boundaries at the ends of TEs has been previously documented, we sought to further characterize the dynamics and mechanism of DNA methylation spreading. To address this, we utilized our high-coverage EM-seq data from Arabidopsis endosperm to investigate the dynamics of DNA methylation spread from individual TEs. We first identified ROS1 TEs that were methylated in wild-type Col-0 endosperm (those that are at least 10% methylated in all sequence contexts; n = 434), as these are TEs from which DNA methylation has the potential to spread. To visualize the molecular phenotype of DNA methylation spreading at individual TEs, we calculated average percent mCG in 100 bp windows of regions flanking TEs for each biological replicate and calculated the difference between the median ros1-3 replicate and the median Col-0 replicate at each window; differences were visualized using a clustered heatmap (Fig. 2B). We observed that DNA methylation spreading from individual TEs appeared to have a primary direction—either from the 5′ or 3′ end of the TE, which was masked in the meta profile (Fig. 2A). However, by definition, the detection of methylation spreading in ros1 is only possible if the proximal region of interest has low levels of methylation in wild-type. To test if bidirectional DNA methylation spread from TEs in a ros1 mutant was possible but did not occur, we separately examined the median wild-type Col-0 value (Fig. 2C, right) and ros13 value (Fig. 2C, left). TEs that were demethylated by ROS1 on both ends were not adjacent to a highly-methylated region on either end in wild-type. In contrast, TEs that appeared to be demethylated by ROS1 on only one end (Fig. 2B) were adjacent to a highly-methylated region on the non-spreading end in wild-type (Fig. 2C). Thus, these TEs lack the capacity for bidirectional spreading in the ros1 mutant. Therefore, spreading direction reflects the surrounding methylation state in wild-type, rather than being an inherently asymmetric process. One caveat to these analyses is the challenge of TE annotation; incorrect TE boundary annotations could obscure where a true TE “end” is. Future work investigating the nature and mechanism of DNA methylation spreading in a ros1 mutant will be valuable for understanding the nature and maintenance of epigenetic boundaries in Arabidopsis.

    To understand the mechanism of spreading in the endosperm, we examined whether methylation spreading was associated with 24-nucleotide small RNAs, which participate in RdDM, in wild-type Col-0 endosperm [41]. The proximal regions of ROS1 TEs produced on average more 24-nt sRNAs in wild-type Col-0 endosperm than in the embryo, whereas the opposite was true for non-ROS1 TEs (Additional file 1: Fig. S7A). However, the data indicated enrichment of endosperm 24-nt sRNAs was driven by only a few ROS1 TEs (Additional file 1: Fig. S7B). To quantify this, we summed the sRNA levels in 2 kb flanking regions of ROS1 TEs and identified TEs with a difference between endosperm and embryo that was 1 standard deviation or more from the mean level. This analysis identified 25 TEs driving the observed endosperm enrichment of sRNAs (Additional file 1: Fig. S7B, Additional file 4: Table S3).

    To further clarify the relationship between ROS1 activity and endosperm 24-nt sRNAs, we quantified DNA methylation levels in ros1-3 and wild-type at regions previously determined to be enriched for 24-nt sRNA production in the endosperm relative to the embryo, referred to as endosperm differential sRNA regions (endosperm DSRs) [41]. Endosperm DSRs were lowly methylated in wild-type endosperm, consistent with previous results [41], and a subset gained DNA methylation in ros1-3 endosperm (Additional file 1: Fig. S7C). To quantify the fraction of endosperm DSRs which are demethylated by ROS1, we calculated a weighted average of CG methylation in endosperm DSRs in Col-0 and ros1-3, calculated the difference between median replicates of both, and filtered DSRs which were at least 30% more CG methylated in ros1-3 than in Col-0. We found 78 DSRs out of 2481 met this stringent threshold. Together, these results suggest that at regions enriched for sRNA production in the endosperm, the low level of DNA methylation observed in wild-type is at least partly a result of ROS1-mediated DNA demethylation, counteracting RdDM.

    ROS1 targets have reduced capacity for hypermethylation in ros1 endosperm

    To determine whether ROS1 acts at unique sites in the endosperm, we investigated the extent to which DNA hypermethylation was tissue-specific. We calculated the level of cytosine methylation at endosperm ros1-3 hyperDMRs (Table 1) in our Col-0 and ros1-3 leaf methylation data as well as in published data from wild-type Col-0 and ros1-3 sperm cells [27]. Sperm methylation was of particular interest because the endosperm is a product of fertilization between a sperm and the central cell. In wild-type plant tissues, ros1-3 CG hyperDMRs displayed DNA methylation features that have been observed at a genome-wide scale: wild-type endosperm has lower DNA methylation levels than does leaf (average 2.8% vs 7.8% in one replicate of each), and sperm has higher DNA methylation levels (~20%) than leaf or endosperm (Fig. 3A, Additional file 1: Fig. S8). Endosperm ros1-3 hyperDMRs were also hypermethylated in ros1 mutant leaf and sperm relative to the respective wild-type tissue (Fig. 3A, Supplemental Figures S4 and S8).

    Fig. 3
    figure 3

    ROS1 targets display limited hypermethylation in endosperm relative to mutant leaf or sperm. A Weighted average fraction mCG in ros1-3 CG hyperDMRs defined in the endosperm (n = 180). Sperm data from Khouider et al. (2021). Plot is a Tukey’s box plot. B Genome browsing example of a ros1-3 CG hyperDMR with limited hypermethylation in ros1-3 mutant endosperm relative to ros1-3 mutant leaf (blue=mCG)

    However, although ROS1 endosperm targets are also ROS1 targets in leaf and sperm, they displayed lower levels of CG DNA methylation in both Col-0 and in ros1 endosperm (Fig. 3A). What underlies the failure to reach the fully hypermethylated state in ros1 endosperm? We considered two non-mutually-exclusive possibilities: (1) these regions are variably methylated among nuclei of ros1 endosperm or (2) these regions are differently methylated between the maternal and paternal genomes in ros1 endosperm. In support of the second hypothesis, ROS1 has been shown to prevent hypermethylation of the paternal allele of the DOGL4 promoter in endosperm (35), and in our data, CG sites in the DOGL4 promoter were less methylated in ros1 endosperm compared to ros1 leaf (Additional file 1: Fig. S9).

    ROS1 prevents hypermethylation on the paternal genome at target loci

    To test if ROS1 targets are differentially methylated between paternal and maternal genomes we performed allele-specific whole-genome EM-seq using F1 endosperm isolated from reciprocal crosses between ros1 mutants in the Col-0 (ros1-3) and C24 (ros1-1) [1] backgrounds, along with appropriate controls. ros1-1 is a nonsense allele (Additional file 1: Fig. S1B). Endosperm nuclei were collected from three replicates each of Col-0 × C24, C24 × Col-0, ros1-3 × ros1-1, ros1-1 × ros1-3, C24 × C24, and ros1-1 × ros1-1 (female parent in cross written first). SNPs between C24 and Col-0 were used to assign reads to a parent-of-origin after sequencing [42] (Additional file 2: Table S1).

    We compared the methylation of maternal and paternal alleles at ros1-3 hyperDMRs in wild-type and ros1 endosperm. In wild type, CG methylation of maternal and paternal alleles at ros1-3 CG hyperDMRs was highly correlated (Pearson’s r = 0.83) (Fig. 4A). In contrast, CG methylation of maternal and paternal alleles at the same regions in ros1 endosperm was not correlated (Pearson’s r = −0.08) (Fig. 4B). The lack of correlation was caused by gain of paternal allele methylation in ros1 endosperm (Fig. 4B). The phenomenon of paternal allele hypermethylation was replicable across ecotypes, as we observed a comparable paternal bias on the C24 genomes at CG hyperDMRs identified between ros1-1 and wild-type C24 endosperm (Fig. 4C–D, Additional file 2: Table S1,). Consistent with these findings, paternal alleles of ROS1 TEs gained more mCG in the ros1-3 mutant than did maternal alleles (Additional file 1: Fig. S10A). Paternal allele hypermethylation of ros1-3 CG hyperDMRs (defined in Col-0) was also observed when the ros1-1 allele was inherited paternally (ros1-3 × ros1-1), indicating overlap among regions where ROS1 prevents paternal hypermethylation in the Col-0 and C24 ecotypes (Additional file 1: Fig. S10B–C).

    Fig. 4
    figure 4

    CG hypermethylation in ros1 mutant endosperm is biased for the paternal allele. Weighted average fraction mCG levels in 418 ros1-3 CG hyperDMRs, averaged across biological replicates, of maternal and paternal wild-type Col-0 alleles (A) and maternal and paternal alleles in ros1-3 (B). Weighted average fraction mCG levels in 346 ros1-1 CG hyperDMRs, averaged across biological replicates, of maternal and paternal wild-type C24 alleles (C) and maternal and paternal alleles in ros1-1 (D). Dashed grey line represents hypothetical perfect correlation between maternal and paternal mCG, not a line of best fit for plotted data. E Genome browser example of the region displayed in Figure 3B, now with distinguished maternal and paternal alleles (blue=mCG, gold=mCHG, green=mCHH)

    We also examined parent-of-origin specific methylation for non-CG hyperDMRs. Contrary to CG hyperDMRs, non-CG hyperDMRs were biallelically hypermethylated in their respective sequence contexts (Additional file 1: Fig. S11). Furthermore, non-CG methylation at ros1-3 CG hyperDMRs was not biased for the paternal allele, although the magnitude of non-CG methylation increase was much less than for CG methylation (Fig. 4E, Additional file 1: Fig. S12). Thus, the observed paternal bias of ROS1 is specific to the CG sequence context. Studies of ROS1 activity in vitro have not revealed a sequence context preference for ROS1 demethylase activity, and in vivo whole-genome sequencing data has repeatedly shown that ROS1 prevents hypermethylation of cytosines in all sequence contexts [2, 8, 43], including the results in the present study of the endosperm (Fig. 1B–D). We propose that it is more likely that the differences observed between sequence contexts indicate ROS1 target regions are differentially targeted by methylation-establishing and maintenance pathways on the maternal and paternal genomes in the endosperm. Overall, ROS1 prevents hypermethylation of the paternal allele more strongly than the maternal allele in the endosperm in the CG sequence context.

    ROS1 promotes a bi-allelically demethylated state in endosperm together with DME

    Greater paternal genome DNA methylation relative to maternal genome DNA methylation is a distinguishing feature of the endosperm epigenome [22, 23]. It is known that wild-type endosperm maternal allele hypomethylation depends, at least in part, on the activity of DME in the central cell before fertilization [3, 6, 22,23,24]. We have shown that ROS1 acts to restrict paternal genome hypermethylation in the endosperm. Considering previous work, we hypothesized that in wild-type endosperm the maternal allele of regions that become hypermethylated in ros1 are demethylated by DME. Using previously published data for maternal genome methylation in endosperm where either dme-2 or wild-type DME were inherited maternally [22], we quantified mCG at ros1-3 CG hyperDMRs and ros1-7 CG hyperDMRs (Additional file 1: Fig. S13). This analysis showed that the maternal alleles of ros1-3 and ros1-7 CG hyperDMRs were hypermethylated in dme heterozygous endosperm (Additional file 1: Fig. S13). As expected, the paternally-inherited allele of these regions, which were wild-type Ler in both cases, were not differentially methylated when dme was inherited maternally (Additional file 1: Fig. S13 A, B). This result suggests that a subset of ROS1 regions are shared demethylase targets, with DME acting on the maternal allele and ROS1 on the paternal allele.

    DME activity on the maternally-inherited genome in the central cell of the female gametophyte establishes parent-of-origin-specific DNA methylation in the endosperm. We propose that ROS1 antagonizes parent-of-origin-specific DNA methylation patterning in the endosperm, resulting in low methylation on both maternal and paternal alleles. To further investigate the role of ROS1 in the context of greater paternal genome methylation in the endosperm, we used our allele-specific methylation data to identify DMRs between maternal and paternal genomes within a wild-type background and within a ros1 mutant background (Table 1). For each genotype, DMRs were called in mCG, mCHG, and mCHH sequence contexts independently, but resulting maternally-hypomethylated DMRs were merged into one list of regions per genotype for subsequent analyses. Regions (n = 1586) that were demethylated on the maternal allele and methylated on the paternal allele in F1 endosperm of all four reciprocal crosses (WT × WT, ros1 × ros1) were likely regions where DME establishes parental DNA methylation asymmetry by acting on the maternally-inherited genome in the central cell before fertilization. This difference is maintained independently of ROS1, and we refer to these as “DME maternal regions” in the following text and figures (Fig. 5A, Table 1, Additional file 5: Table S4). Regions defined as maternally-hypomethylated in both ros1 × ros1 cross directions, but neither WT × WT cross direction were also identified, and based on subsequent analyses we refer to these as “ROS1 paternal, DME maternal regions” in the following text and figures (Fig. 5B, Table 1, Additional file 5: Table S4). These regions (n = 274) lacked DNA methylation on both alleles in wild-type endosperm, and gained DNA methylation relative to wild-type predominantly on the paternal allele in the absence of ROS1. Hypomethylation of the maternal allele relative to the paternal allele is observable in the ros1 mutant background at these regions (Fig. 5B). This suggests that in the wild type, the maternal allele of these regions lacks methylation due to a ROS1-independent mechanism, whereas the paternal allele is demethylated by ROS1 (Fig. 5B). The presence of ROS1 paternal, DME maternal regions, in addition to the paternal bias in CG hypermethylation at ros1 hyperDMRs (Fig. 4), indicates a role for ROS1 in preventing differential DNA methylation between maternal and paternal genomes in the endosperm, specifically differential methylation where the paternal allele is more highly methylated than the maternal allele.

    Fig. 5
    figure 5

    ROS1 prevents parent-of-origin specific methylation in the endosperm. A A diagram and a genome browsing example of a presumed DME maternal region in the endosperm (blue=mCG, gold=mCHG, green=mCHH). B A diagram and a genome browsing example of a presumed ROS1 and DME shared target in the endosperm, referred to as ROS1 paternal, DME maternal (blue=mCG, gold=mCHG, green=mCHH). Region shown is approximately Chr1:10,173,740-10,173,965

    We tested our assumption that maternally-demethylated regions in wild-type endosperm that were not dependent on ROS1 for proper methylation state (Fig. 5A, “DME maternal regions”) were demethylated by DME. Examination of methylation levels in and flanking these regions using published dme allele-specific endosperm data [22] indicated maternal allele hypermethylation compared to wild-type, confirming these regions as canonical DME targets (Fig. 6A, C, Additional file 1: Fig. S14A). We also examined whether maternal allele hypomethylation at ROS1 paternal, DME maternal regions was, as we hypothesized, dependent on DME. We observed maternal allele hypermethylation in dme endosperm at these regions but to a lesser extent than at DME maternal regions (Fig. 6B, D, Additional file 1: Fig. S14B). We repeated these analyses using an independent, non-allelic dme mutant endosperm dataset [24], which further confirmed that DME prevents hypermethylation at DME and ROS1 regions (Additional file 1: Fig. S15). Together, these results indicate that DME, in part, prevents hypermethylation of the maternal allele and ROS1 prevents hypermethylation of the paternal allele at some regions that are biallelically-demethylated in wild-type endosperm. Other factors are also likely involved in maternal allele hypomethylation of these regions. For example, it is possible that methyltransferases, such as MET1, do not maintain methylation of the maternal allele at these sites in the central cell and early endosperm, which could also prevent full maternal allele methylation irrespective of DNA demethylase activity.

    Fig. 6
    figure 6

    ROS1 promotes a biallelically demethylated state by preventing hypermethylation of the paternal allele. Percent CG methylation of maternal and paternal genomes from selected biological replicates in ros1-1 × ros1-3 and C24 × Col-0 F1 endosperm (reciprocal cross plotted in Additional file 1: Fig. S15) across 50 bp windows, 400 bp inside and 1 kb outside each aligned end of DME maternal regions (A) and 200 bp inside and 1 kb outside each aligned end of ROS1 paternal, DME maternal regions (B). Different distances were evaluated inside the two classes of DMRs to account for the differences in average length (Additional file 1: Fig. S2). Percent CG methylation of maternal and paternal genomes in dme-2/+ × Ler and Col-0 × Ler F1 endosperm across 50 bp windows, 400 bp inside and 1 kb outside each aligned end of DME maternal regions (C) and 200 bp inside and 1 kb outside each aligned end of ROS1 paternal, DME maternal regions. dme methylation data from Ibarra et al. (2012) (D)

    Relationship between ROS1 and DME in the endosperm

    We further investigated the relationship between ROS1 and DME function and targets in the endosperm. To identify the genome neighborhood of ROS1 and DME endosperm targets, we plotted the density of DMRs in 100 kb windows across chromosomes, plotting a rolling average of 10 windows (Fig. 7A). We found that ROS1 targets, both ros1-3 hyperDMRs and ROS1 paternal, DME maternal regions, were evenly distributed across chromosomes (Fig. 7A, green and pink lines). DME maternal regions, however, were denser in pericentromeric regions (Fig. 7A, gold line). This is consistent with previous results showing that endosperm vs embryo hypoDMRs, indicative of DME activity in the central cell, match the distribution of transposable elements in the genome [23]. In prior work, ROS1 and DME have been associated with distinct genomic features with regards to TEs. ROS1 targets TEs of any length, especially the ends of TEs near gene [8, 10]. In euchromatic regions, DME has been reported to demethylate the bodies of shorter TEs [22,23,24]. We quantified the number of DME maternal regions and ROS1 paternal, DME maternal regions within 1 kb or intersecting a gene or TE (Fig. 7B). More than 86% of DME maternal regions and 75% of ROS1 paternal, DME maternal regions were associated with TEs (Fig. 7B).

    Fig. 7
    figure 7

    Relationship between ROS1 and DME in the endosperm. A Rolling average of DMR coverage density (left y-axis) and fraction mCG (right y-axis) in 100 kb windows across chromosome 3. B The number of DME maternal regions and ROS1 paternal, DME maternal regions within 1 kb or intersecting genomic features of interest. C Percent CG methylation of Col-0 and ros1-3 maternal and paternal genomes from selected biological replicates in F1 endosperm across 100 bp windows, 2 kb inside and 2 kb outside each aligned end of TEs within 1 kb or intersecting a DME maternal region. D The difference between median ros1-3 mCG and median Col-0 mCG value at each 100 bp window 2 kb outside and 2 kb inside of DME TEs. Note that non-allelic data is used for clustered heatmaps. E Genome browser example of a TE targeted by DME, where ROS1 prevents DNA methylation spreading from the 5′ end of the TE (blue=mCG, gold=mCHG, green=mCHH). dme-2 endosperm data from Ibarra et al., 2012. F The fraction of chromatin states, defined using data from seedling tissue by Sequeira-Mendes et al. (2014), represented in endosperm DMRs of each class.

    We observed that the flanking regions of DME maternal regions were more highly methylated in wild-type endosperm than were flanking regions of ROS1 paternal, DME maternal regions, most notably on the paternal allele (Fig. 6A, B, compare yellow lines). We also observed a slight increase in CG methylation on the paternal allele at regions flanking DME maternal regions in the ros1 mutant endosperm (Fig. 6A, green vs. yellow line). We hypothesized that this may be indicative of a relationship between regions targeted by DME alone and regions targeted by both DME and ROS1. We quantified the distance between each ROS1 paternal, DME maternal region to the nearest DME maternal region to test their proximity. The majority of regions were greater than 15 kb away from one another, but about 10% of ROS1 paternal, DME maternal regions were within 1 kb of a DME maternal region (Additional file 1: Fig. S16). Given the frequent proximity of both ROS1 paternal, DME maternal regions and DME maternal regions to TEs, we investigated if ROS1 might be preventing DNA methylation spread at the ends of TEs that are demethylated by DME. We identified 3263 TEs that were within 1 kb or intersecting a maternally-demethylated region (DME TEs) and calculated allele-specific DNA methylation levels in wild-type and ros1 (Fig. 7C). As expected, DME-targeted TE bodies and flanking regions were methylated on the paternal allele (50–70% mCG), but the maternal allele was less methylated (~30–60% mCG) in TE bodies and flanking regions (Fig. 7C). A small increase in paternal allele CG methylation at regions flanking DME TEs was observed in the ros1 mutant endosperm (Fig. 7C; green vs. yellow lines). To assess how widespread this phenomenon was, we calculated the difference between the median value of mCG in ros1-3 and Col-0 for DME TEs and plotted these using a clustered heatmap (Fig. 7D, Additional file 1: Fig. S17). This visualization shows that ROS1 prevents methylation spreading at a small subset of DME TE ends. To quantify this, we identified 653 TEs that met a threshold of one window or more with at least 30% higher methylation in ros1-3 than in Col-0. Using this definition, 20% of DME targeted-TEs showed some ROS1-dependency in their flanking regions in the endosperm. By genome browsing, we observed TEs that were maternally demethylated in a DME-dependent manner and where ROS1 prevented DNA methylation spreading into TE-flanking regions, predominantly on the paternal allele (Fig. 7E).

    Although some DME maternal regions were proximal to ROS1 paternal, DME maternal regions (Fig. 7C–E), the majority were not (Additional file 1: Fig. S16). Thus we further investigated features that might distinguish ROS1 and DME target regions, examining the overlap with 9 chromatin states defined in seedling tissue [44]. Consistent with the distribution of DMRs (Fig. 7A), we found that in seedling tissue DME maternal regions were enriched in H3K9me2-marked heterochromatin in intergenic regions and TEs, with 66% of DME maternal regions found in chromatin state 8 (Fig. 7F). The largest single fraction of chromatin states represented in both ros1-3 and ros1-7 hyperDMRs was also state 8, but together there was more representation of states 4 and 5 (45.8% for ros1-3 hyperDMRs), which are marked by H3K27me3 and correspond to upstream regions of promoters and intergenic regions, respectively (Fig. 7F). The largest fraction of ROS1 paternal, DME maternal regions, 48%, were found in chromatin state 4, indicating these shared targets of ROS1 and DME are mostly found in upstream promoter regions marked by H3K27me3 (Fig. 7F). One limitation of this analysis is that it is unknown whether these same chromatin states are present in endosperm tissue. We thus further focused our investigation on H3K27me3 profiles in the endosperm. Using published data from H3K27me3 profiling in Col × Ler endosperm at 4 days after pollination, we evaluated if ROS1 and DME regions were coincident with H3K27me3 peaks in the endosperm [45]. We found that 32% and 64% of ros1-3 and ros1-7 hyperDMRs, respectively, were associated with an H3K27me3 peak in endosperm tissue. By contrast, ~20% of DME regions were associated with an endosperm H3K27me3 peak. ROS1 paternal, DME maternal regions were in between these values, with ~29% of regions associated with an H3K27me3 peak in endosperm. These results are consistent with the chromosomal localization and chromatin state of these regions, as H3K27me3 is relatively depleted from pericentromeric regions.

    We also investigated ROS1 and DME target regions with regards to imprinting and gene expression in the endosperm. ROS1 and DME have been shown to act together to promote expression of genes in the vegetative nucleus of pollen, ultimately promoting proper pollen germination [27]. In the endosperm, DME maternal regions are associated with imprinted genes [31] (Additional file 6: Table S5). Although parent of origin-specific DNA methylation is not an absolute requirement for gene imprinting [30], the relatively demethylated status of both maternal and paternal alleles at ROS1 paternal, DME maternal regions suggests that they are likely not involved in regulation of gene imprinting. Consistent with this notion, no imprinted genes were within 1 kb of or intersecting ROS1 paternal, DME maternal regions. To investigate any differences in expression of DMR-associated genes in the seed, we utilized a single-nucleus RNA sequencing atlas of developing wild-type Arabidopsis seeds [36]. We found that the expression of genes near DME maternal regions was enriched in the endosperm compared to the embryo or seed coat, but that the expression of genes near ROS1 and ROS1/DME targets were not enriched in endosperm relative to embryo or seed coat. (Additional file 1: Fig. S18).

    We conclude that both ROS1 and DME demethylate TEs, especially those near genes. A subset of TEs demethylated by DME are further demethylated by ROS1 in their flanking regions. However, ROS1 and DME targets are distinguished by their chromosomal distribution and their coincidence with different chromatin states. Furthermore, known imprinted genes are found near DME maternal regions, but not near ROS1 paternal, DME maternal regions. Overall, the functional consequence of co-targeting by DME and ROS1, either on gene expression or chromatin state, is unclear.

    Inheritance of wild-type ROS1 does not rescue hypermethylation in F1 heterozygous endosperm

    How and why does ROS1 primarily effect paternal allele methylation state in the endosperm? One explanation is that paternal allele-specific demethylation of these regions occurs in the endosperm after fertilization. This would mean that ROS1 selectively acts on paternal alleles despite the presence of maternal alleles. Another, not mutually-exclusive, possibility is that demethylation by ROS1 after fertilization is not allele-specific but that there is no methylation actively established or maintained on the maternal allele to be removed at this point in development. Finally, the paternally-biased effect of ROS1 in the endosperm could be a product of ROS1 activity pre-fertilization, with the consequent methylation state inherited and maintained after fertilization. Although not expressed in mature pollen or sperm, ROS1 is expressed in the microspore and bicellular pollen (Additional file 1: Fig. S19) [46, 47] and ROS1 endosperm targets are hypermethylated in ros1 sperm (Fig. 3). Thus, ROS1 could act prior to fertilization in the male germline, leading to inheritance of a demethylated paternal allele in the endosperm, without a requirement for active demethylation of these regions by ROS1 in the developing endosperm after fertilization.

    Based on our comparisons between sperm and endosperm DNA methylation data, we sought to test if inheritance of a wild-type ROS1 allele is sufficient for paternal genome hypomethylation in the endosperm. More specifically, is the paternal allele hypermethylation that is observed in ros1 endosperm at ROS1 paternal, DME maternal regions rescued in the presence of a wild-type ROS1 allele that is inherited maternally? We reasoned that if ROS1 acts only through the male germline, then a wild-type paternal ROS1 allele would be necessary for demethylation of the paternal endosperm genome, and a wild-type maternal ROS1 allele would be insufficient. To test this hypothesis, we performed allele-specific methylation profiling on endosperm of F1 seed derived from reciprocal crosses between ros1-3 (in the Col-0 background) and wild-type C24 (Fig. 8A). In this design, the F1 endosperm is heterozygous for the ros1 mutation but either the maternal or paternal sporophytic tissues and female or male gametophytes are null for ROS1. If ROS1 activity is required before fertilization in the paternal sporophyte or male gametophyte to cause hypomethylation of paternal alleles in the endosperm after fertilization, then ROS1 paternal, DME maternal regions will be paternally hypermethylated in heterozygous ros1-3 endosperm when the mutation is inherited through the paternal parent. In contrast, under this model maternal inheritance of ros1 should not result in paternal allele hypermethylation in heterozygous endosperm. If ROS1 instead acts after fertilization to demethylate paternal alleles in endosperm, then paternal allele hypermethylation will not be observed in heterozygous ros1-3 endosperm when the mutation is inherited through the paternal parent.

    Fig. 8
    figure 8

    Maternal inheritance of wild-type ROS1 in the endosperm is not sufficient for complete demethylation of paternal alleles. A Graphical depiction of experimental design. To compare genomes inherited from a wild-type ROS1 background to genomes inherited from a mutant ros1 background in the endosperm, we reciprocally crossed wild-type C24 and ros1-3. F1 endosperm is heterozygous for a wild-type copy of ROS1. B Weighted average fraction mCG of the paternal allele of ROS1 paternal, DME maternal regions (n = 262). Values are averaged across biological replicates of ros1-1 × ros1-3 F1 endosperm (y-axis) or C24 × ros1-3 F1 heterozygous endosperm (x-axis). Paternal allele methylation was significantly correlated between the homozygous and heterozygous F1 endosperm, where the ros1-3 allele was inherited paternally. The y-intercept of the line of best fit (red line) indicates that regions are more hypermethylated in the homozygous ros1 condition than in the heterozygous ros1 condition. C Weighted average fraction mCG of the paternal allele of ROS1 paternal, DME maternal regions (n = 262) represented as a Tukey’s box plot, showing gain of paternal allele methylation in ros1 +/−. Maternally-inherited ROS1 is not sufficient for complete paternal genome demethylation after fertilization. Additional samples and statistics in Additional file 1: Figs. S20, S21

    We compared the paternal genome average CG methylation level in WT, ros1, and ros1/+ endosperm at ROS1 paternal, DME maternal regions (Fig. 8B). Paternal allele methylation was correlated between the heterozygous and homozygous ros1-3 endosperm, when ros1-3 was inherited paternally (Fig. 8B). We observed that paternal alleles were highly methylated in the C24 × ros1-3 F1 heterozygous endosperm, like in ros1 endosperm, relative to wild-type paternal alleles (Fig. 8C, Additional file 1: Fig. S20, “ros1-3 paternal”). Thus, inheritance of a wild-type maternal ROS1 allele is not sufficient for wild-type mCG levels at ROS1 paternal, DME maternal regions. We also observed little difference in methylation on maternally-inherited alleles between heterozygous and homozygous ros1 mutants relative to wild-type; maternal allele methylation was low in these regions regardless of the ROS1 genotype (Additional file 1: Fig. S20 “ros1-3 maternal”). We conclude that the majority of paternal allele hypermethylation in ros1 mutant endosperm is inherited through the male germline. Thus, in wild-type, the majority of regions are demethylated by ROS1 prior to fertilization. However, we observed a slight, non-significant, reduction in paternal mCG at ROS1 and DME regions in the ros1/+ F1 heterozygous endosperm relative to the ros1 homozygous endosperm (Fig. 8B–C, Additional file 1: Fig. S20 “ros1-3 paternal”) indicative of active maternal ROS1 in the endosperm after fertilization that is able to partially rescue paternal CG hypermethylation. However, in the same C24 × ros1-3 F1 heterozygous endosperm, methylation of maternal alleles (inherited from C24) of ROS1 paternal, DME maternal regions was also decreased (Additional file 1: Fig. S20, “C24 maternal”), so this reduction is likely not indicative of specific ROS1 activity on paternal alleles only in the endosperm post-fertilization.

    We also investigated the role of maternally and paternally-inherited ROS1 in the endosperm at the larger set of ros1-3 CG hyperDMRs. Paternal allele methylation was also correlated between C24 × ros1-3 F1 heterozygous endosperm and ros1-1 × ros1-3 F1 endosperm at ros1-3 CG hyperDMRs (Additional file 1: Fig. S21). Maternally-inherited wild-type ROS1 was not sufficient for wild-type methylation levels on paternal alleles of ros1-3 CG hyperDMRs (Additional file 1: Fig. S21B, “ros1-3 paternal”). We again observed a slight decrease in paternal allele hypermethylation at some ros1-3 CG hyperDMRs in the ros1/+ F1 heterozygous endosperm (Additional file 1: Fig. S21A, 21B “ros1-3 paternal”). Additionally, we observed a non-significant increase in paternal allele mCG in the ros1/+ F1 heterozygous endosperm when ros1-3 was inherited maternally (Additional file 1: Fig. S21B, “C24 paternal”), further implicating maternally-inherited ROS1 in preventing hypermethylation at a subset of ROS1 target regions in the endosperm after fertilization. Overall, we conclude that paternal allele CG methylation patterning at ROS1 regions is largely inherited through the male germline, but some ROS1 regions are actively demethylated by ROS1 in the endosperm on both maternal and paternal alleles, post-fertilization.

    Finally, as it has been shown that ROS1 and DME act together at some regions in pollen [27], we investigated whether DME had any role in the male germline at ROS1 target regions. As expected, ROS1 paternal, DME maternal regions were hypermethylated in ros1-3 mutant sperm relative to wild-type sperm (Additional file 1: Fig. S22A). In sperm collected from dme-2 heterozygous plants, ROS1 paternal, DME maternal regions were not hypermethylated (Additional file 1: Fig. S22A), although sufficient sperm methylation data was only available for 103 regions. To evaluate more ROS1 target regions, we performed the same analysis using ros1-3 and ros1-7 CG hyperDMRs. There was a significant increase in CG methylation at ros1-3 and ros1-7 CG hyperDMRs in dme-2 heterozygous sperm compared to wild-type, although of a lower magnitude than that observed in ros1 sperm, suggesting DME is partially capable of demethylating ROS1 target regions earlier in development, which could further impact paternal allele methylation in the endosperm (Additional file 1: Fig. S22B–C). Overall, these results are consistent with previous reports that DME contributes to demethylation in somatic tissues and in the pollen vegetative nucleus, but not to the same extent as ROS1 [20, 48].

    Continue Reading

  • UPC Legal Compass: Decisions by default – missing procedural deadlines at the UPC remains a consequential mishap

    As has been demonstrated repeatedly and all parties involved in UPC proceedings should be aware, the UPC sticks strictly to its deadline regime and is very hesitant to grant any extensions of procedural deadlines.

    Such deadlines or missing such deadlines does come with consequences. In numerous cases the UPC has found that late filed submission and any included factual or legal argument may and will be disregarded for its final decision.

    But besides simply disregarding a late filed argument, the UPC in certain circumstances can also issue decisions by default against either party covering the full extent of the respective request on the merits of the other side, even without an oral hearing.

     

    LEGAL FRAMEWORK

    The relevant provision for issuing a decision by default is Rule 355 of the Rules of Procedure (RoP). R. 355.1 RoP mentions two alternatives when a decision by default may be issued. For one a decision by default can be issued when specifically provided for in the RoP or in case a party does not take a specific step within the applicable time limit and secondly a decision by default can be taken when a party fails to appear at the oral hearing.

    Besides the default, depending on who the decision by default is to be issued against, certain other requirements need to be met for the court to issue such a decision. In case the decision is to be issued against the respective claimant of the action, no additional requirement needs to be fulfilled. Conversely, if a decision by default is to be issued against the defendant, effectively granting the requested remedy, R. 355.2. and 3 RoP specify that a decision by default may only be given where the facts submitted by the claimant are sufficient to justify the remedy and at least the time limit for filing a defence has expired.

    If the aforementioned requirements have been met and there are no other abnormal procedural circumstances, then issuing the decision still requires the court to exercise its discretion based on the specifics of the case.

    To this end the Court of Appeal has already decided that exercising discretion must be based on the principle of fairness and equity and be reflective of the goal of conducting proceedings in the most efficient and effective manner as well as balance the interests of the parties. In this context, the Court of Appeal takes into account to the benefit of the party against whom the decision is taken, that the RoP provide for a special appeal against decisions by default in R. 356 RoP (CoA, UPC_CoA_363/2025, para. 23 and 25).

    In the context of exercising discretion, the Paris Central Division has previously decided that, since the facts put forward by the claimant justified the remedy sought and generally the non-defaulting party is entitled to a speedy procedure without delay. The court more generally held that expeditious decisions are one of the aims of the UPC Agreement and that the legal framework of the UPC gives the defendant adequate means to justify the default and to appeal an unfavorable decision (CD Paris, UPC-CFI_412/2023, para 12). Thus, suggesting that in most cases there should be a strong indication in favor of granting the decision by default provided the relevant requirements are met.

     

    Examples of relevant Defaults
    1. Failure to submit Statement of Defense / Appeal Response

    The Düsseldorf and Munich Local Divisions have both previously decided that a default judgment can be issued in principle if the defendant fails to file a written statement of defense within the applicable (LD Düsseldorf, UPC-CFI_318/2025, para. 18; LD Munich, UPC_CFI_193/2024, p. 10, the finding was in part based on Article 37.1 of the Statute of the UPC explicitly mentioning this possibility).

    The Court of Appeal has followed similar proceedings albeit based on R. 235.3 RoP. Thereby finding that a reasoned decision can be given on appeal if the respondent fails to lodge a statement of response. The Court of Appeal found that this reasoned decision is effectively a default decision. Hence, the possibility to file an application to set aside the decision according to R. 356.1 RoP (i.e. the remedy provided for default judgments under R. 355 RoP) also applies to reasoned decisions (CoA, UPC_CoA_363/2025, para. 23).

    1. Failure to provide Security for Costs

    Another, quite important, example of decisions by default being issued by the UPC is where the court has requested the claimant to provide a security for costs (R. 158.5 RoP). Such a request can be filed by defendants in case the financial situation of the claimant is unclear, and any potential reimbursement claim thus potentially de facto unenforceable.

    Several divisions of the UPC have already issued decisions finding that if such a security is not provided by the claimant in the set time limit, then a decision by default dismissing the complaint generally has to be issued. Since in those cases the decisions by default are issued against the claimant no assessment of the facts submitted will be necessary, but the default itself is already sufficient to justify the decision (R. 355.2 and 3 RoP are only applicable in case a decision by default is to be issued against the defendant, cf. CoA, UPC_CoA_363/2025, para. 16 subs; see also CD Milan, UPC_CFI_597/2024).

    If at the same time a decision by default regarding a counterclaim by the defendant is requested, then failing to provide a security will also be sufficient default for that purpose. However, since for the purposes of the counterclaim the roles of defendant and claimant are reversed, in order for a decision by default to be issued for the respective counterclaim as well, the facts submitted by the defendant will have to be sufficient to justify the requested remedy.

    For such cases the Court of Appeal held that issuing decisions by default ensures the effectiveness of security for costs ordered under R. 158 RoP. It is only under exceptional circumstances that the Court may derogate from this general rule, effectively making the exercise of discretion less relevant in such cases. The reference to the status quo or merits of the action is not sufficient to deviate from that general rule (CoA, UPC_CoA_363/2025, para. 24).

    Continue Reading

  • Imran expresses grievances in letter to CJP Afridi, urges him to direct IHC to fix ‘critical’ petitions – Pakistan

    Imran expresses grievances in letter to CJP Afridi, urges him to direct IHC to fix ‘critical’ petitions – Pakistan

    PTI founder Imran Khan has written a letter to Chief Justice of Pakistan (CJP) Yahya Afridi, it emerged on Thursday as party leader Latif Khosa delivered it to the top judge at the Supreme Court.

    In the letter dated September 16, a copy of which is available with Dawn.com, Imran expressed grievances over several matters, including the conditions he has been kept in inside jail, and urged CJP Afridi to direct the Islamabad High Court to fix some “critical petitions” that had been “hanging in the doldrums” for hearing.

    The petitions he was referring to pertain to Toshakhana and Al Qadir Trust cases.

    Speaking to the media after delivering Imran’s letter, Khosa said the CJP had sought the ex-premier’s complaints regarding the conditions in jail in writing and assured that his grievances would be addressed and responded to within 24 hours.

    He said, “We will inform you about whatever happens in [the next] 24 hours.”

    Khosa said he had also expressed “our reservations” about the judiciary to the chief justice and raised the matter of jail reforms.

    “The CJP has sought suggestions over jail reforms,” he said.

    Earlier, Imran’s sister Aleema Khanum had reached the court with the PTI founder’s letter, where she was reportedly barred from meeting the CJP by police. Khosa was later allowed access to the chief justice.

    The letter

    Imran began his letter with complaints about jail conditions, saying: “For over 772 days, from a cage measuring 9 x 11, from a dungeon of enforced silence, isolation and incommunicado, I have endured continued solitary confinement … All access to books and newspapers has been denied to me.”

    “Meetings with my lawyers and family are “arbitrarily cancelled at the whims and wishes of one man”, Imran claimed, referring to the army chief.

    He also alleged that his sons were barred from talking to him on phone and political workers were also not allowed to see him.

    “It is not lawful imprisonment since its inception; it is only calculated psychological torture, crafted to break my will … It is an ongoing assault on the Constitution, the rule of law and the democratic future of my beloved homeland, Pakistan,” he continued.

    The PTI founder also complained of “inhuman and degrading treatment” being meted out to his wife, Bushra Bibi, in jail, alleging that she was being denied medical treatment and access to books and television.

    He pointed out that superior courts have held that “female prisoners are entitled to leniency through bail as a matter of right”.

    Yet, in Bushra Bibi’s case, “this principle has been suspended”, he said.

    The former premier then went on highlight that “thousands of my supporters and party workers continue to languish in jails” and had been “abducted, beaten and subjected to military trials in flagrant violation of constitutional protections”.

    He also expressed grievances with regards to the “political victimisation” of his family members.

    “Courts that should stand as guardians of liberty have been weaponised to dismantle Pakistan’s largest political party,” the further said.

    Imran maintained that his PTI secured a “landslide victory” in last year’s general elections “despite the brutal tactics, the suppression of all bold voices, despite my own imprisonment”.

    “Yet, the mandate of the people was stolen overnight, turning democracy into [a] farce and the Constitution into a casualty. The same has been sanctioned and rubber-stamped by the leaked report of Commonwealth 2024,” he wrote.

    Although the Comm­on­wealth Observer Group’s (COG) report on Pakistan has yet to be officially released, news outlet Drop Site News claimed that the group had “buried their report” after finding those polls to be riddled with problems.

    Imran further said that “the so-called 26th Constitutional Amendment has been used as a tool to sanctify this electoral dacoity, while petitions challenging it lie unheard in your (CJP’s) court”.

    CJP Afridi had ignored a decision made last year by a committee to bring challenges to the 26th Amendment before the full apex court, according to minutes of the communication exchange between the chief justice and two senior SC judges.

    Imran also wrote about the allegedly “questionable conduct of the Islamabad High Court under its chief justice, a byproduct of the 26th Amendment; Justice Sarfaraz Dogar, who deliberately refuses to fix my Al-Qadir trust petitions and the Toshakhana revision petitions”.

    “He has fully abandoned impartiality and reduced Islamabad High Court to a facilitator of unjust and tyrannical campaign against me and those associated with me,” Imran alleged. “I remind him to fulfil his oath, instead of hiding behind frivolous ‘policy reasons’ to justify not hearing my petitions.”

    He then urged the CJP to direct the IHC to fix the aforementioned petitions for hearing. He added, “I, as the patron-in-chief of Pakistan’s largest political party, seeks only what the Constitution guarantees: justice, dignity and equality before law. I therefore request immediate hearings of the pending petitions before all courts. Allow all telephone calls to my sons as mandated by the jail manual, grant access to Bushra Bibi’s doctors for her medical treatment, and ultimately restore judicial independence of the judiciary in Pakistan.”

    Imran concluded his letter, saying: “The courage of the verdicts you inscribe in the book of this nation’s destiny will go down in history … I urge Your Lordship to uphold the oath of your office and show the people that the Supreme Court of Pakistan remains their final refuge of justice.”

    Continue Reading